What is the Caplin Point Laboratories Ltd share price today?

The share price of NSE:CAPLIPOINT-EQ on 01 Oct 2026 (as of 15:03:16 IST) is ₹2620.

What is the NSE:CAPLIPOINT-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:CAPLIPOINT-EQ 52 week high low range shows a high of ₹2990 and a low of ₹1500.3.

What is the Caplin Point Laboratories Ltd market cap?

As on 01 Oct 2026, Caplin Point Laboratories Ltd market cap is ₹205900000000.

What is the shareholding pattern of Caplin Point Laboratories Ltd Stock?

The shareholding pattern of Caplin Point Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 70.57% Foreign Institutional Investors (FII): 5.75% Domestic Institutional Investors (DII): 0.46% Mutual Funds: 2.03% Retail & Others: 21.19% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Caplin Point Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Caplin Point Laboratories Ltd is 30.9462, and the Price-to-Book (PB) ratio is 3.2744, as on 01 Oct 2026.

Caplin Point Laboratories Share Price

2649.10-30.60 (-1.14%)

+31.05% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.14%

1 Week

+0.65%

1 Month

-5.86%

3 Month

+1.06%

6 Month

+55.06%

YTD

+44.12%

1 Year

+31.05%

5 Year

+196.07%

10 Year

+861.21%

Max

+7645.91%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

2610.00

2541.10

2490.50

2382.50

1649.00

1500.30

High

2689.00

2691.20

2990.00

About

Caplin Point Laboratories is engaged in manufacture of pharmaceuticals formulations. It is a fast-growing Indian pharmaceutical company with global reach, having a 100% export-oriented business. The company supplies a complete Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

CAPLIPOINTNSE

LTP

1W Low

1W High

Market cap (₹)

1781-20 (-1.11%)

1768

1804.20

4,32,120Cr

9588+339 (3.67%)

9113.50

9660

2,53,390Cr

4716.2-51.1 (-1.07%)

4679

4795

1,81,740Cr

1153+7.3 (0.64%)

1128.10

1167.40

1,15,710Cr

2052.8+68.8 (3.47%)

1955.10

2065.20

1,10,980Cr

1327.2-16.8 (-1.25%)

1321

1351

1,08,497Cr

2500-35 (-1.38%)

2464.50

2539.30

1,02,650Cr

1203.8-2.4 (-0.20%)

1189

1222.80

1,00,925Cr

1682+5.2 (0.31%)

1663.10

1698.90

97,239Cr

2012.9-18.3 (-0.90%)

1996.30

2031.40

93,059Cr

2649.1+17.2 (0.65%)

2541.10

2691.20

20,365Cr

Caplin Point Laboratories Share Price

2649.10-30.60 (-1.14%)

+31.05% past 1 Year

Financial overview

Compounded Sales Growth

10 years25%

5 years16%

3 years14%

Last year13%

Compounded Profit Growth

10 years30%

5 years21%

3 years19%

Last year20%

Stock Price CAGR

10 years26%

5 years25%

3 years35%

1 year33%

Return on Equity

10 years31%

5 years23%

3 years22%

Last year21%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
25%	16%	14%	13%
30%	21%	19%	20%
26%	25%	35%	33%
31%	23%	22%	21%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

MANKIND

DRREDDY

AUROPHARMA

LUPIN

CAPLIPOINT

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,781	₹432120 Cr	35.73	12.07	62.82	₹11479 Cr
9,588	₹253390 Cr	86.63	34.04	128.41	₹2568 Cr
4,716.2	₹181740 Cr	83.33	16.72	97.06	₹2163 Cr
1,153	₹115710 Cr	25.64	9.42	62.53	₹5040 Cr
2,052.8	₹110980 Cr	101.5	6.8	29.25	₹889 Cr
1,327.2	₹108497 Cr	32.19	9.77	57.87	₹3879 Cr
2,500	₹102650 Cr	50.25	13.75	71.08	₹1913 Cr
1,203.8	₹100925 Cr	31.32	5.32	63.99	₹4196 Cr
1,682	₹97239 Cr	26.19	17.95	96.84	₹3505 Cr
2,012.9	₹93059 Cr	16.83	30.95	154.35	₹5333 Cr
2,649.1	₹20365 Cr	30.61	23.28	97.81	₹641 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹610 Cr	₹600 Cr	₹543 Cr	₹534 Cr	₹510 Cr	₹502 Cr	₹493 Cr	₹483 Cr	₹459 Cr	₹453 Cr	₹436 Cr	₹410 Cr	₹395 Cr	₹389 Cr	₹372 Cr	₹359 Cr	₹346 Cr	₹339 Cr	₹326 Cr	₹304 Cr	₹300 Cr	₹279 Cr	₹274 Cr	₹268 Cr	₹240 Cr	₹215 Cr	₹228 Cr	₹227 Cr	₹193 Cr	₹187 Cr	₹159 Cr	₹156 Cr	₹146 Cr	₹143 Cr	₹142 Cr	₹131 Cr	₹124 Cr	₹118 Cr	₹103 Cr	₹96 Cr	₹85 Cr	₹82 Cr	₹79 Cr	₹78 Cr	₹70 Cr	₹64 Cr	₹61 Cr	₹57 Cr	₹48 Cr	₹43 Cr	₹43 Cr	₹41 Cr	₹39 Cr	₹29 Cr	₹32 Cr	₹27 Cr
₹34 Cr	₹28 Cr	₹34 Cr	₹30 Cr	₹23 Cr	₹26 Cr	₹31 Cr	₹21 Cr	₹19 Cr	₹17 Cr	₹17 Cr	₹20 Cr	₹12 Cr	₹11 Cr	₹14 Cr	₹16 Cr	₹14 Cr	₹12 Cr	₹10 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹2 Cr	₹6 Cr	₹20 Cr	₹10 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹8 Cr	₹7 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹90 L	₹91 L	₹70 L	₹81 L	₹71 L	₹91 L	₹1 Cr	₹95 L	₹55 L	₹39 L	₹41 L	₹56 L	₹4 Cr
₹644 Cr	₹629 Cr	₹576 Cr	₹564 Cr	₹533 Cr	₹528 Cr	₹524 Cr	₹504 Cr	₹478 Cr	₹471 Cr	₹453 Cr	₹430 Cr	₹407 Cr	₹401 Cr	₹386 Cr	₹376 Cr	₹360 Cr	₹351 Cr	₹336 Cr	₹312 Cr	₹310 Cr	₹288 Cr	₹280 Cr	₹270 Cr	₹247 Cr	₹235 Cr	₹239 Cr	₹234 Cr	₹197 Cr	₹190 Cr	₹167 Cr	₹163 Cr	₹148 Cr	₹146 Cr	₹144 Cr	₹135 Cr	₹127 Cr	₹122 Cr	₹105 Cr	₹98 Cr	₹86 Cr	₹83 Cr	₹80 Cr	₹78 Cr	₹71 Cr	₹64 Cr	₹62 Cr	₹58 Cr	₹49 Cr	₹44 Cr	₹44 Cr	₹41 Cr	₹40 Cr	₹29 Cr	₹32 Cr	₹31 Cr
₹419 Cr	₹415 Cr	₹372 Cr	₹363 Cr	₹349 Cr	₹351 Cr	₹347 Cr	₹335 Cr	₹323 Cr	₹324 Cr	₹307 Cr	₹284 Cr	₹280 Cr	₹276 Cr	₹274 Cr	₹265 Cr	₹255 Cr	₹251 Cr	₹237 Cr	₹214 Cr	₹220 Cr	₹203 Cr	₹200 Cr	₹190 Cr	₹177 Cr	₹170 Cr	₹169 Cr	₹163 Cr	₹133 Cr	₹129 Cr	₹107 Cr	₹106 Cr	₹99 Cr	₹101 Cr	₹95 Cr	₹86 Cr	₹81 Cr	₹80 Cr	₹74 Cr	₹71 Cr	₹66 Cr	₹64 Cr	₹59 Cr	₹59 Cr	₹55 Cr	₹50 Cr	₹50 Cr	₹47 Cr	₹40 Cr	₹33 Cr	₹34 Cr	₹36 Cr	₹36 Cr	₹24 Cr	₹27 Cr	₹23 Cr
₹247 Cr	₹233 Cr	₹223 Cr	₹220 Cr	₹201 Cr	₹194 Cr	₹194 Cr	₹186 Cr	₹170 Cr	₹163 Cr	₹159 Cr	₹158 Cr	₹139 Cr	₹135 Cr	₹124 Cr	₹122 Cr	₹116 Cr	₹111 Cr	₹111 Cr	₹110 Cr	₹102 Cr	₹95 Cr	₹90 Cr	₹89 Cr	₹78 Cr	₹73 Cr	₹78 Cr	₹78 Cr	₹72 Cr	₹67 Cr	₹65 Cr	₹63 Cr	₹55 Cr	₹52 Cr	₹53 Cr	₹53 Cr	₹50 Cr	₹48 Cr	₹34 Cr	₹30 Cr	₹24 Cr	₹22 Cr	₹24 Cr	₹22 Cr	₹20 Cr	₹16 Cr	₹14 Cr	₹13 Cr	₹10 Cr	₹12 Cr	₹10 Cr	₹6 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹8 Cr
₹18 L	₹36 L	₹18 L	₹16 L	₹18 L	₹17 L	₹18 L	₹21 L	₹5 L	₹15 L	₹17 L	₹18 L	₹28 L	₹23 L	₹36 L	₹14 L	₹6 L	₹8 L	₹14 L	₹21 L	₹27 L	₹32 L	₹28 L	₹48 L	₹51 L	₹17 L	₹6 L	₹8 L	₹1 L	₹1 L	₹2 L	₹2 L	₹1 L	₹1 L	₹2 L	₹2 L	₹2 L	₹2 L	₹2 L	₹5 L	₹3 L	₹3 L	₹5 L	₹3 L	₹10 L	₹4 L	₹5 L	₹5 L	₹5 L	₹2 L	₹2 L	₹4 L	₹15 L	₹3 L	₹2 L	₹11 L
₹225 Cr	₹213 Cr	₹204 Cr	₹201 Cr	₹184 Cr	₹177 Cr	₹177 Cr	₹169 Cr	₹154 Cr	₹146 Cr	₹145 Cr	₹146 Cr	₹127 Cr	₹124 Cr	₹112 Cr	₹110 Cr	₹105 Cr	₹100 Cr	₹99 Cr	₹98 Cr	₹90 Cr	₹85 Cr	₹80 Cr	₹80 Cr	₹69 Cr	₹65 Cr	₹70 Cr	₹71 Cr	₹64 Cr	₹61 Cr	₹60 Cr	₹57 Cr	₹49 Cr	₹45 Cr	₹49 Cr	₹48 Cr	₹46 Cr	₹43 Cr	₹31 Cr	₹27 Cr	₹21 Cr	₹19 Cr	₹21 Cr	₹19 Cr	₹16 Cr	₹15 Cr	₹12 Cr	₹11 Cr	₹9 Cr	₹11 Cr	₹10 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹7 Cr
₹179 Cr	₹173 Cr	₹166 Cr	₹160 Cr	₹151 Cr	₹145 Cr	₹140 Cr	₹131 Cr	₹125 Cr	₹121 Cr	₹120 Cr	₹116 Cr	₹104 Cr	₹101 Cr	₹97 Cr	₹92 Cr	₹86 Cr	₹81 Cr	₹79 Cr	₹77 Cr	₹72 Cr	₹68 Cr	₹66 Cr	₹63 Cr	₹55 Cr	₹49 Cr	₹59 Cr	₹57 Cr	₹50 Cr	₹50 Cr	₹46 Cr	₹43 Cr	₹37 Cr	₹35 Cr	₹37 Cr	₹36 Cr	₹36 Cr	₹33 Cr	₹24 Cr	₹22 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹14 Cr	₹13 Cr	₹11 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹8 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹5 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Minority Interest

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹90 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹51 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr
₹18 Cr	₹20 Cr	₹14 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹9 Cr	₹7 Cr	₹3 Cr	₹9 L	₹2 Cr	₹0	₹0	₹0	₹0	₹0
₹3478 Cr	₹2741 Cr	₹2212 Cr	₹1775 Cr	₹1379 Cr	₹1081 Cr	₹849 Cr	₹575 Cr	₹345 Cr	₹210 Cr	₹111 Cr	₹78 Cr	₹47 Cr	₹28 Cr	₹18 Cr	₹14 Cr
₹3478 Cr	₹2741 Cr	₹2212 Cr	₹1775 Cr	₹1379 Cr	₹1081 Cr	₹849 Cr	₹575 Cr	₹345 Cr	₹210 Cr	₹108 Cr	₹74 Cr	₹43 Cr	₹24 Cr	₹15 Cr	₹10 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr
₹3586 Cr	₹2850 Cr	₹2316 Cr	₹1880 Cr	₹1484 Cr	₹1186 Cr	₹948 Cr	₹633 Cr	₹364 Cr	₹225 Cr	₹128 Cr	₹93 Cr	₹62 Cr	₹43 Cr	₹34 Cr	₹29 Cr
₹44 Cr	₹36 Cr	₹31 Cr	₹27 Cr	₹26 Cr	₹18 Cr	₹9 Cr	₹8 L	₹9 L	₹36 L	₹27 L	₹27 L	₹18 L	₹9 L	₹5 L	₹3 L
₹0	₹0	₹0	₹0	₹0	₹0	₹2 L	₹29 L	₹32 L	₹48 L	₹73 L	₹88 L	₹2 Cr	₹3 Cr	₹2 Cr	₹8 L
₹5 Cr	-₹2 Cr	-₹13 Cr	-₹14 Cr	-₹6 Cr	₹1 Cr	₹10 Cr	₹18 Cr	₹22 Cr	₹19 Cr	₹11 Cr	₹9 Cr	₹8 Cr	₹5 Cr	₹2 Cr	₹2 Cr
₹15 Cr	₹14 Cr	₹11 Cr	₹8 Cr	₹10 Cr	₹11 Cr	₹10 Cr	₹5 Cr	₹5 Cr	₹5 L	₹0	₹0	₹0	₹0	₹0	₹0
₹1 Cr	₹2 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹13 L	₹0	₹40 L	₹2 Cr	₹82 L	₹81 L	₹38 L	₹27 L	₹20 L
₹21 Cr	₹13 Cr	₹8 Cr	₹2 Cr	₹13 Cr	₹17 Cr	₹25 Cr	₹23 Cr	₹28 Cr	₹20 Cr	₹14 Cr	₹10 Cr	₹10 Cr	₹9 Cr	₹4 Cr	₹2 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹296 Cr	₹218 Cr	₹230 Cr	₹153 Cr	₹156 Cr	₹89 Cr	₹64 Cr	₹60 Cr	₹94 Cr	₹79 Cr	₹56 Cr	₹42 Cr	₹32 Cr	₹26 Cr	₹21 Cr	₹17 Cr
₹69 Cr	₹64 Cr	₹90 Cr	₹100 Cr	₹49 Cr	₹52 Cr	₹79 Cr	₹24 Cr	₹14 Cr	₹33 Cr	₹60 Cr	₹72 Cr	₹66 Cr	₹51 Cr	₹38 Cr	₹11 Cr
₹57 L	₹55 L	₹28 L	₹3 Cr	₹50 L	₹0	₹0	₹0	₹0	₹0	₹0	₹5 L	₹5 L	₹5 L	₹5 Cr	₹9 Cr
₹20 Cr	₹24 Cr	₹11 Cr	₹12 Cr	₹3 Cr	₹2 Cr	₹91 L	₹1 Cr	₹58 L	₹2 Cr	₹9 Cr	₹11 Cr	₹10 Cr	₹6 Cr	₹4 Cr	₹3 Cr
₹386 Cr	₹306 Cr	₹331 Cr	₹268 Cr	₹208 Cr	₹143 Cr	₹144 Cr	₹86 Cr	₹109 Cr	₹113 Cr	₹125 Cr	₹125 Cr	₹108 Cr	₹83 Cr	₹69 Cr	₹40 Cr
₹4038 Cr	₹3206 Cr	₹2686 Cr	₹2177 Cr	₹1730 Cr	₹1364 Cr	₹1126 Cr	₹743 Cr	₹500 Cr	₹358 Cr	₹267 Cr	₹229 Cr	₹180 Cr	₹135 Cr	₹107 Cr	₹71 Cr
₹18 Cr	₹64 L	₹64 L	₹64 L	₹71 L	₹1 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹7 Cr	₹8 Cr	₹3 Cr	₹4 Cr	₹3 Cr
₹57 L	₹55 L	₹28 L	₹3 Cr	₹50 L	₹17 Cr	₹36 Cr	₹54 L	₹54 L	₹72 L	₹2 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹7 Cr	₹10 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹965 Cr	₹859 Cr	₹702 Cr	₹480 Cr	₹446 Cr	₹423 Cr	₹355 Cr	₹272 Cr	₹232 Cr	₹195 Cr	₹181 Cr	₹143 Cr	₹123 Cr	₹50 Cr	₹43 Cr	₹40 Cr
₹385 Cr	₹313 Cr	₹250 Cr	₹201 Cr	₹159 Cr	₹117 Cr	₹82 Cr	₹45 Cr	₹62 Cr	₹43 Cr	₹37 Cr	₹30 Cr	₹21 Cr	₹17 Cr	₹16 Cr	₹15 Cr
₹580 Cr	₹546 Cr	₹453 Cr	₹280 Cr	₹287 Cr	₹305 Cr	₹273 Cr	₹227 Cr	₹169 Cr	₹152 Cr	₹144 Cr	₹113 Cr	₹102 Cr	₹33 Cr	₹28 Cr	₹25 Cr
₹209 Cr	₹139 Cr	₹117 Cr	₹220 Cr	₹15 Cr	₹14 Cr	₹20 Cr	₹10 Cr	₹15 Cr	₹3 Cr	₹23 L	₹30 Cr	₹24 Cr	₹49 Cr	₹13 Cr	₹17 L
₹473 Cr	₹279 Cr	₹138 Cr	₹71 Cr	₹37 Cr	₹66 L	₹56 L	₹33 L	₹33 L	₹13 Cr	₹44 L	₹45 L	₹44 L	₹1 Cr	₹1 Cr	₹1 Cr
₹473 Cr	₹279 Cr	₹138 Cr	₹71 Cr	₹37 Cr	₹66 L	₹56 L	₹33 L	₹33 L	₹13 Cr	₹44 L	₹45 L	₹44 L	₹1 Cr	₹1 Cr	₹1 Cr
₹151 Cr	₹89 Cr	₹78 Cr	₹52 Cr	₹90 Cr	₹8 Cr	₹10 Cr	₹12 Cr	₹11 Cr	₹11 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹11 Cr	₹12 Cr	₹4 Cr
₹14 Cr	₹15 Cr	₹7 Cr	₹3 Cr	₹1 Cr	₹21 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1452 Cr	₹1072 Cr	₹793 Cr	₹625 Cr	₹432 Cr	₹349 Cr	₹303 Cr	₹249 Cr	₹196 Cr	₹179 Cr	₹149 Cr	₹147 Cr	₹131 Cr	₹96 Cr	₹53 Cr	₹30 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹386 Cr	₹311 Cr	₹238 Cr	₹210 Cr	₹52 Cr	₹11 Cr	₹60 Cr	₹70 Cr	₹46 Cr	₹4 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹429 Cr	₹336 Cr	₹363 Cr	₹288 Cr	₹227 Cr	₹179 Cr	₹238 Cr	₹37 Cr	₹28 Cr	₹22 Cr	₹19 Cr	₹14 Cr	₹10 Cr	₹10 Cr	₹6 Cr	₹5 Cr
₹826 Cr	₹632 Cr	₹543 Cr	₹394 Cr	₹317 Cr	₹279 Cr	₹229 Cr	₹160 Cr	₹126 Cr	₹33 Cr	₹8 Cr	₹6 Cr	₹9 L	₹86 L	₹7 Cr	₹8 Cr
₹621 Cr	₹591 Cr	₹553 Cr	₹493 Cr	₹463 Cr	₹438 Cr	₹223 Cr	₹153 Cr	₹79 Cr	₹93 Cr	₹68 Cr	₹45 Cr	₹27 Cr	₹17 Cr	₹32 Cr	₹22 Cr
₹98 Cr	₹77 Cr	₹50 Cr	₹23 Cr	₹14 Cr	₹20 Cr	₹15 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹11 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹2 Cr
₹226 Cr	₹186 Cr	₹146 Cr	₹143 Cr	₹225 Cr	₹87 Cr	₹57 Cr	₹65 Cr	₹17 Cr	₹19 Cr	₹13 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹3 Cr
₹2586 Cr	₹2134 Cr	₹1893 Cr	₹1552 Cr	₹1298 Cr	₹1015 Cr	₹823 Cr	₹494 Cr	₹304 Cr	₹179 Cr	₹119 Cr	₹82 Cr	₹49 Cr	₹39 Cr	₹54 Cr	₹41 Cr
₹2200 Cr	₹1828 Cr	₹1562 Cr	₹1284 Cr	₹1090 Cr	₹872 Cr	₹678 Cr	₹408 Cr	₹195 Cr	₹66 Cr	-₹7 Cr	-₹43 Cr	-₹59 Cr	-₹44 Cr	-₹15 Cr	₹81 L
₹4038 Cr	₹3206 Cr	₹2686 Cr	₹2177 Cr	₹1730 Cr	₹1364 Cr	₹1126 Cr	₹743 Cr	₹500 Cr	₹358 Cr	₹267 Cr	₹229 Cr	₹180 Cr	₹135 Cr	₹107 Cr	₹71 Cr
₹460	₹363	₹293	₹236	₹184	₹145	₹114	₹78	₹48	₹30	₹81	₹59	₹38	₹26	₹20	₹17
₹460	₹363	₹293	₹236	₹184	₹145	₹114	₹78	₹48	₹30	₹16	₹12	₹8	₹5	₹4	₹3

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011
₹803 Cr	₹677 Cr	₹564 Cr	₹451 Cr	₹386 Cr	₹314 Cr	₹269 Cr	₹227 Cr	₹188 Cr	₹121 Cr	₹60 Cr	₹53 Cr	₹36 Cr	₹22 Cr	₹11 Cr	₹8 Cr
-₹26 Cr	₹6 Cr	₹2 Cr	₹12 Cr	₹30 Cr	₹23 Cr	₹7 Cr	₹19 Cr	₹15 Cr	₹9 Cr	₹4 Cr	₹6 Cr	₹2 Cr	-₹21 L	-₹25 L	₹2 Cr
-₹109 Cr	-₹122 Cr	-₹139 Cr	-₹104 Cr	₹2 Cr	-₹2 Cr	-₹177 Cr	-₹120 Cr	-₹100 Cr	-₹38 Cr	-₹5 Cr	₹2 Cr	₹29 Cr	₹16 Cr	₹19 Cr	₹4 Cr
₹668 Cr	₹560 Cr	₹427 Cr	₹359 Cr	₹418 Cr	₹335 Cr	₹99 Cr	₹126 Cr	₹103 Cr	₹91 Cr	₹59 Cr	₹62 Cr	₹67 Cr	₹38 Cr	₹30 Cr	₹15 Cr
₹523 Cr	₹432 Cr	₹318 Cr	₹271 Cr	₹337 Cr	₹269 Cr	₹45 Cr	₹83 Cr	₹66 Cr	₹68 Cr	₹42 Cr	₹50 Cr	₹60 Cr	₹32 Cr	₹28 Cr	₹14 Cr
-₹582 Cr	-₹335 Cr	-₹320 Cr	-₹218 Cr	-₹377 Cr	-₹29 Cr	-₹55 Cr	-₹100 Cr	-₹69 Cr	-₹36 Cr	-₹6 Cr	-₹23 Cr	-₹44 Cr	-₹45 Cr	-₹16 Cr	-₹7 Cr
-₹46 Cr	-₹38 Cr	-₹38 Cr	-₹28 Cr	-₹41 Cr	-₹24 Cr	₹80 Cr	₹90 Cr	-₹12 Cr	-₹7 Cr	-₹14 Cr	-₹9 Cr	-₹6 Cr	-₹1 Cr	-₹1 Cr	-₹37 L
-₹106 Cr	₹59 Cr	-₹40 Cr	₹26 Cr	-₹81 Cr	₹215 Cr	₹70 Cr	₹73 Cr	-₹14 Cr	₹25 Cr	₹23 Cr	₹19 Cr	₹10 Cr	-₹15 Cr	₹10 Cr	₹7 Cr
₹199 Cr	₹139 Cr	₹178 Cr	₹151 Cr	₹232 Cr	₹221 Cr	₹151 Cr	₹77 Cr	₹91 Cr	₹67 Cr	₹45 Cr	₹27 Cr	₹17 Cr	₹32 Cr	₹22 Cr	₹15 Cr
-₹8 Cr	-₹6 Cr	-₹5 Cr	-₹7 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹25 L	₹1 Cr	₹86 L	₹1 Cr	-₹9 L	-₹24 L	₹17 L	₹72 L	-₹80,000	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹87 Cr	₹194 Cr	₹134 Cr	₹171 Cr	₹151 Cr	₹436 Cr	₹221 Cr	₹151 Cr	₹77 Cr	₹91 Cr	₹68 Cr	₹45 Cr	₹27 Cr	₹17 Cr	₹32 Cr	₹22 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Caplin Point Laboratories Share Price

2649.10-30.60 (-1.14%)

+31.05% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Caplin Point Laboratories Share Price

2649.10-30.60 (-1.14%)

+31.05% past 1 Year

Shareholding summary

Promoters

70.57%

FII

5.75%

DII

0.46%

2.03%

Others

21.19%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
70.57%	70.57%	70.57%	70.57%	70.56%	70.56%
5.75%	6.15%	6.55%	6.48%	6.17%	5.73%
0.46%	0.12%	0.08%	0.31%	0.29%	0.26%
2.03%	2.02%	1.97%	1.79%	1.93%	1.74%
21.19%	21.14%	20.83%	20.85%	21.05%	21.71%

Bulk & block deals

Name

Graviton Research Capital Llp

Xtx Markets Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 Aug 2024	Purchase	75.29 Cr	₹1,899.60	3.96 L	Bulk	0.521439	NSE
26 Aug 2024	Sell	75.36 Cr	₹1,901.28	3.96 L	Bulk	0.521439	NSE
19 Aug 2024	Purchase	78.30 Cr	₹1,761.72	4.44 L	Bulk	0.584749	NSE
19 Aug 2024	Sell	78.39 Cr	₹1,763.58	4.44 L	Bulk	0.584749	NSE
09 Sep 2021	Purchase	34.63 Cr	₹908.19	3.81 L	Bulk	0.501641	NSE
09 Sep 2021	Sell	34.64 Cr	₹908.54	3.81 L	Bulk	0.501641	NSE
27 Jul 2021	Purchase	39.74 Cr	₹957.62	4.15 L	Bulk	0.545944	NSE
27 Jul 2021	Sell	39.73 Cr	₹957.37	4.15 L	Bulk	0.545944	NSE
26 Jul 2021	Purchase	42.19 Cr	₹908.91	4.64 L	Bulk	0.610699	NSE
26 Jul 2021	Sell	41.96 Cr	₹910.58	4.61 L	Bulk	0.606244	NSE

Insider trading & SAST

Client name

P Vijayalakshmi

Sathish Krishnan

Arulsudar Natrajan

Subramanian Narayanaswamy

Subramanian Narayanswamy

Vijayarangam R M

Venkatachalam P

Vamsee Krishna Tata

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Mar 2023	Promoter Group	Acquisition	1.184134	24.74	54.74 Cr	₹609	8.99 L	23 Mar 2023	Gift	1,87,78,790	Insider Trading	—	Equity Shares
24 Nov 2021	Employee	Disposal	0.006609	0	40.58 L	₹811.51	5 K	23 Nov 2021	Market Sale	0	Insider Trading	—	Equity Shares
24 Nov 2021	Employee	Disposal	0.001983	0	12.46 L	₹831	1.50 K	22 Nov 2021	Market Sale	0	Insider Trading	—	Equity Shares
24 Nov 2021	Employee	Disposal	0.002644	0	16.64 L	₹832	2 K	22 Nov 2021	Market Sale	1,500	Insider Trading	—	Equity Shares
19 Nov 2021	Employee	Disposal	0.001983	0	12.99 L	₹866.05	1.50 K	17 Nov 2021	Market Sale	3,500	Insider Trading	—	Equity Shares
19 Nov 2021	Employee	Disposal	0.000132	0	87 K	₹870	100	17 Nov 2021	Market Sale	100	Insider Trading	—	Equity Shares
19 Nov 2021	Employee	Disposal	0.006477	0	42.52 L	₹867.75	4.90 K	17 Nov 2021	Market Sale	200	Insider Trading	—	Equity Shares
08 Nov 2021	Employee	Acquisition	0.003305	0	5 K	₹2	2.50 K	02 Nov 2021	ESOP	2,500	Insider Trading	—	Equity Shares
08 Nov 2021	Employee	Acquisition	0.004406	0	6.67 K	₹2	3.33 K	02 Nov 2021	ESOP	3,333	Insider Trading	—	Equity Shares
08 Nov 2021	Employee	Acquisition	0.003305	0	5 K	₹2	2.50 K	02 Nov 2021	ESOP	2,500	Insider Trading	—	Equity Shares

Caplin Point Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Caplin Point Laboratories Share Price

Caplin Point Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Caplin Point Laboratories Share Price

Caplin Point Laboratories Share Price

Oscillators

Moving averages

Caplin Point Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Caplin Point Laboratories Share Price

Corporate Actions

Company details

Caplin Point Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Caplin Point Laboratories Share Price

News

Caplin Point subsidiary Caplin Steriles receives USFDA Form 483 with 10 observations

Caplin Point Lab reports higher Q1 EBITDA with margin expansion

Caplin Point Lab reports 26 percent rise in US market Q1 FY27 revenue

Caplin Point Lab reports higher Q1 revenue of Rs 610 crores

Caplin Point Lab posts higher Q1 net profit at Rs 177 crore year on year

Caplin Point Laboratories’ arm gets USFDA approval for Foscarnet Sodium injection

Caplin Point Lab - Quaterly Results

Caplin Point Laboratories informs about outcome of board meeting

Caplin Point Laboratories Plans Expansion into Regulated Markets Including Canada, Australia, MENA, Russia/CIS, Mexico, Brazil

Caplin Point Lab reports Profit after tax of 109.50 Crores, in the March 2026 quarter

Caplin Point Laboratories Q4 EBITDA Rises 21% YoY to Rs 204 Crores, Margin Contracts to 34.03%

Caplin Point Labs Q4 FY26 Revenue Growth at 19.5% YoY to Rs 600 Crores

Caplin Point Labs Q4 Consolidated Net Profit Rises 17.2% YoY to Rs 170 Crores

Caplin Point gains as its arm gets USFDA’s approval for Calcium Gluconate Injection

Caplin Point’s arm gets USFDA’s approval for Calcium Gluconate Injection

Caplin Point Lab's Caplin Steriles Secures USFDA Approval for Calcium Gluconate Injection.

Caplin Point’s arm gets USFDA’s final nod for Potassium Phosphates Injection

Caplin Point Laboratories informs about press release

Caplin Point Laboratories Subsidiary Caplin Steriles Secures USFDA Approval for Potassium Phosphates Injection.

Caplin Point’s arm secures USFDA’s final approval for Desmopressin Acetate Injection

Caplin Point Laboratories Ltd Share Price Today

Caplin Point Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator